The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration

Cancer Biology and Therapy

Volumn 7, Issue 5, 2008, Pages 677-688

  Murakami, Masanao ^a   Meneses, Patricio I ^b   Lan, Ke ^c   Robertson, Erle S ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cdc42; Cell migration; Dbl 1; Nm23 H1; Rac1

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A; ONCOPROTEIN; ONCOPROTEIN DBL 1; PLECKSTRIN; PROTEIN CDC42; RAC1 PROTEIN; REGULATOR PROTEIN; RHO FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MCF2 PROTEIN, HUMAN; NME1 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PHOSPHOPROTEIN; PLASMA PROTEIN; PLATELET PROTEIN P47;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL GROWTH; CELL MATURATION; CELL MEMBRANE; CELL MIGRATION; CELL STRAIN COS7; CONTROLLED STUDY; H118F GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; METASTASIS; MUTANT; P96S GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR SUPPRESSOR GENE; ANIMAL; BIOLOGICAL MODEL; CELL MOTION; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; CYTOPLASM; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ANIMALS; BLOOD PROTEINS; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PHOSPHOPROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS;

EID: 45349099560     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.5.5665     Document Type: Article

References (67)

1. Bajaj BG, Murakami M and Robertson ES. Molecular biology of EBV in relationship to AIDS-associated oncogenesis. Cancer Treat Res 2007; 133:141-62.
2. Bhujwalla ZM, Aboagye EO, Gillies RJ, Chacko VP, Mendola CE and Backer JM. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro. Magn Reson Med 1999; 41:897-903.
3. Bi F, Debreceni B, Zhu K, Salani B, Eva A and Zheng Y. Autoinhibition mechanism of proto-Dbl. Mol Cell Biol 2001; 21:1463-74.
4. Boguski MS and McCormick F. Proteins regulating Ras and its relatives. Nature 1993; 366:643-54.
5. Cavallaro U and Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4:118-32.
6. Cerione RA and Zheng Y. The Dbl family of oncogenes. Curr Opin Cell Biol 1996; 8:216-22.
7. Chandrachud LM, Grindlay GJ, McGarvie GM, O'Neil BW, Wagner ER, Jarrett WF and Campo MS. Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology 1995; 211:204-8.
8. Chimini G and Chavrier P. Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2000; 2:191-6.
9. de la Rosa A, Williams RL and Steeg PS. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 1995; 17:53-62.
10. Etienne Manneville S and Hall A. Rho GTPases in cell biology. Nature 2002; 420:629-35.
11. Eva A and Aaronson SA. Isolation of a new human oncogene from a diffuse B-cell lymphoma. Nature 1985; 316:273-5.
12. Eva A and Aaronson SA. Isolation of a new human oncogene from a diffuse B-cell lymphoma. Nature 1985; 316:273-5.
13. Eva A, Vecchio G, Diamond M, Tronick SR, Ron D, Cooper GM and Aaronson SA. Independently activated dbl oncogenes exhibit similar yet distinct structural alterations. Oncogene 1987; 1:355-60.
14. Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA and Collard JG. Rho family proteins in cell adhesion and cell migration. Eur J Cancer 2000; 36:1269-74.
15. Fan Z, Beresford PJ, Oh DY, Zhang D and Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112:659-72.
16. Garcia Mata R and Burridge K. Catching a GEF by its tail. Trends Cell Biol 2007; 17:36-43.
17. Gilles AM, Presecan E, Vonica A and Lascu I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991; 266:8784-9.
18. Graziani G, Ron D, Eva A and Srivastava SK. The human dbl-proto-oncogene product is a cytoplasmic phosphoprotein which is associated with the cytoskeletal matrix. Oncogene 1989; 4:823-9.
19. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR and et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 1991; 88:341-5.
20. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279:509-14.
21. Hall A and Nobes CD. Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci 2000; 355:965-70.
22. Hartsough MT, Morrison DK, Salerno M, Palmieri D, Ouatas T, Mair M, Patrick J and Steeg PS. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 2002; 277:32389-99.
23. Haslam RJ, Koide HB and Hemmings BA. Pleckstrin domain homology. Nature 1993; 363:309-10.
24. Kamynina E, Kauppinen K, Duan F, Muakkassa N and Manor D. Regulation of protooncogenic dbl by chaperone-controlled, ubiquitin-mediated degradation. Mol Cell Biol 2007; 27:1809-22.
25. Kantor JD, McCormick B, Steeg PS and Zetter BR. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 1993; 53:1971-3.
26. Katoh H, Hiramoto K and Negishi M. Activation of Rac1 by RhoG regulates cell migration. J Cell Sci 2006; 119:56-65.
27. Kaul R, Murakami M, Choudhuri T and Robertson ES. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J Virol 2007; 81:10352-61.
28. Kaul R, Verma SC, Murakami M, Lan K, Choudhuri T and Robertson ES. Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1. J Virol 2006; 80:1321-31.
29. Kauppinen KP, Duan F, Wels JI and Manor D. Regulation of the Dbl proto-oncogene by heat shock cognate protein 70 (Hsc70). J Biol Chem 2005; 280:21638-44.
30. Kharbanda S, Pandey P, Ren R, Mayer B, Zon L and Kufe D. c-Abl activation regulates induction of the SEK1/stress-activated protein kinase pathway in the cellular response to 1-beta-D-arabinofuranosylcytosine. J Biol Chem 1995; 270:30278-81.
31. Knight JS, Sharma N and Robertson ES. SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol Cell Biol 2005; 25:1749-63.
32. Kraemer A, Brinkmann T, Plettner I, Goody R and Wittinghofer A. Fluorescently labelled guanine nucleotide binding proteins to analyse elementary steps of GAP-catalysed reactions. J Mol Biol 2002; 324:763-74.
33. Lemmon MA and Ferguson KM. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J 2000; 350:1-18.
34. Lemmon MA, Ferguson KM and Abrams CS. Pleckstrin homology domains and the cytoskeleton. FEBS Lett 2002; 513:71-6.
35. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA and Steeg PS. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991; 65:25-35.
36. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ and Steeg PS. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993; 8:855-65.
37. Lieberman J and Fan Z. Nuclear war: the granzyme A-bomb. Curr Opin Immunol 2003; 15:553-9.
38. Liu X, Mayeda A, Tao M and Zheng ZM. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3′ splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway. J Virol 2003; 77:2105-15.
39. MacDonald NJ, De la Rosa A, Benedict MA, Freije JM, Krutsch H and Steeg PS. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 1993; 268:25780-9.
40. Mayer BJ, Ren R, Clark KL and Baltimore D. A putative modular domain present in diverse signaling proteins. Cell 1993; 73:629-30.
41. Murakami M, Lan K, Subramanian C and Robertson ES. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J Virol 2005; 79:1559-68.
42. Murakami M, Meneses PI, Knight JS, Lan K, Verma SC and Robertson ES. Nm23-H1 Modulates the activity of the Guanine exhange factor Dbl-1. Int J Cancer 2008; in press.
43. Nakamori S, Ishikawa O, Ohhigashi H, Kameyama M, Furukawa H, Sasaki Y, Inaji H, Higashiyama M, Imaoka S, Iwanaga T and et al. Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 1993; 11:151-8.
44. Nishida K, Kaziro Y and Satoh T. Association of the proto-oncogene product dbl with G protein betagamma subunits. FEBS Lett 1999; 459:186-90.
45. Nobes CD and Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81:53-62.
46. Nosaka K, Kawahara M, Masuda M, Satomi Y and Nishino H. Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. Biochem Biophys Res Commun 1998; 243:342-8.
47. Oda Y, Naka T, Takeshita M, Iwamoto Y and Tsuneyoshi M. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Hum Pathol 2000; 31:709-16.
48. Otsuki Y, Tanaka M, Yoshii S, Kawazoe N, Nakaya K and Sugimura H. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci USA 2001; 98:4385-90.
49. Palacios F, Schweitzer JK, Boshans RL and D'Souza Schorey C. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol 2002; 4:929-36.
50. Postel EH, Berberich SJ, Rooney JW and Kaetzel DM. Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr 2000; 32:277-84.
51. Raftopoulou M and Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004; 265:23-32.
52. Razzini G, Brancaccio A, Lemmon MA, Guarnieri S and Falasca M. The role of the pleckstrin homology domain in membrane targeting and activation of phospholipase Cbeta(1). J Biol Chem 2000; 275:14873-81.
53. Ron D, Tronick SR, Aaronson SA and Eva A. Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells. Embo J 1988; 7:2465-73.
54. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80:200-4.
55. Steeg PS, Ouatas T, Halverson D, Palmieri D and Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003; 4:51-62.
56. Subramanian C, Cotter MA, 2nd and Robertson ES. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med 2001; 7:350-5.
57. Subramanian C and Robertson ES. The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription. J Virol 2002; 76:8702-9.
58. Tatsumoto T, Xie X, Blumenthal R, Okamoto I and Miki T. J Cell Biol 1999; 147:921-8.
59. Tee YT, Chen GD, Lin LY, Ko JL and Wang PH. Nm23-H1: a metastasis-associated gene. Taiwan J Obstet Gynecol 2006; 45:107-13.
60. Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F and Versteeg R. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 2005; 65:3136-45.
61. Van Aelst L and D'Souza Schorey C. Rho GTPases and signaling networks. Genes Dev 1997; 11:2295-322.
62. Vanni C, Mancini P, Gao Y, Ottaviano C, Guo F, Salani B, Torrisi MR, Zheng Y and Eva A. Regulation of proto-Dbl by intracellular membrane targeting and protein stability. J Biol Chem 2002; 277:19745-53.
63. Wallet V, Mutzel R, Troll H, Barzu O, Wurster B, Veron M and Lacombe ML. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst 1990; 82:1199-202.
64. Welch DR and Hunter KW. A new member of the growing family of metastasis suppressors identified in prostate cancer. J Natl Cancer Inst 2003; 95:839-41.
65. Whitehead IP, Campbell S, Rossman KL and Der CJ. Dbl family proteins. Biochim Biophys Acta 1997; 1332:1-23.
66. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem Sci 2001; 26:724-32.
67. Zheng Y, Zangrilli D, Cerione RA and Eva A. The pleckstrin homology domain mediates transformation by oncogenic dbl through specific intracellular targeting. J Biol Chem 1996; 271:19017-20.